ENPP1 is an innate immune checkpoint of the anticancer cGAMP-STING pathway
S. Wang, V. Bohnert, A. J. Joseph, V. Sudaryo, J. Swinderman, F. B. Yu, X. Lyu, G. Skariah, V. Subramanyam, L. A. Gilbert, H. Goodarzi, L. Li
This study identifies ENPP1 as an innate immune checkpoint that suppresses the cGAMP-STING pathway, promoting tumor growth and metastasis, and shows that inhibiting its cGAMP hydrolase activity enhances cancer immunity.
bioRxiv · Jun 1, 2023 · PreprintCancer Biology